ArticleJournal of neuro-oncology2017

Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin.

Iwan E Bennett et al.PubMed ↗Publisher ↗

No numbers read from the abstract.